Oncotect

Raleigh, United States

Oncotect is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine.

$200K raised

Feb 2023

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Oncotect raised?

Oncotect has raised $200K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2023.

Who are Oncotect's investors?

Oncotect's investors include Leap Venture Studio, North Carolina Biotechnology Center, Michelson Impact Ventures, NC IDEA MICRO.

Where is Oncotect headquartered?

Oncotect is headquartered in Raleigh, United States.

What does Oncotect do?

Oncotect is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine.

What stage is Oncotect at?

Oncotect is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 27, 2023.

MLA

"Oncotect — Funding & Investors." VCBacked, February 27, 2023, https://www.vcbacked.co/company/oncotect. Accessed July 2, 2026.

APA

VCBacked. (2023). Oncotect — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/oncotect

Wikipedia (cite web)

{{cite web |title=Oncotect — Funding & Investors |url=https://www.vcbacked.co/company/oncotect |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 27, 2023.